Let's focus on what we can do!

Facebook Twitter Instagram Linkedin
What are you looking for?

By Disabled People for Disabled People

  • Home
  • >
  • Ataxia
  • >
  • Portage’s Biohaven orphan drug designation request granted for the treatment of spinocerebellar ataxia – PR Newswire (press release)

Portage’s Biohaven orphan drug designation request granted for the treatment of spinocerebellar ataxia – PR Newswire (press release)

Wednesday, 9 March, 2016

Categories

Portage’s Biohaven orphan drug designation request granted for the treatment of spinocerebellar ataxia – PR Newswire (press release)

Vlad Coric, M.D., CEO of Biohaven, added, "Receiving the orphan drug designation request for spinocerebellar ataxia supports our global development strategy and goal of providing improved therapies for patients suffering from neurologic disorders with ...

Read More

Source:Portage's Biohaven orphan drug designation request granted for the treatment of spinocerebellar ataxia - PR Newswire (press release)

Categories :
  • Ataxia , 
  • Latest Headlines , 
  • Uncategorized
Socials :

Recent posts

@abilitytoday
Let's share our
memories
@abilitytodayuk
Let's be
friends
@abilitytoday
Let's chat and hear
your voice
@ability-today
Let's get down to
Business
Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Our Awards and Partners

Disability confident Logo
Donate to Ability Today CIC
(A Social Enterprise)

Copyright © 2023 All rights reserved

Facebook Twitter Instagram Linkedin